Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6770)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 7, 2025 (publication date) through Oct 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang XE, Zhang SJ, Liu Y, Yao SY, Zhang SX, Liu XM, Liang LX, Wang F. Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better? World J Gastroenterol 2025; 31(13): 100863 [PMID: 40248055 DOI: 10.3748/wjg.v31.i13.100863] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v31/i13/100863.htm |
| Number | Citing Articles |
| 1 |
Karolina Kornatowska, Edyta Hańczyk, Dawid Piecuch, Szymon Kopciał, Natalia Pawelec, Weronika Mazur, Mateusz Tyniec, Kamal Morshed. A Novel Approach to H. pylori Eradication: A Narrative Review of Vonoprazan-Based Therapies. Gastroenterology Insights 2025; 16(3): 35 doi: 10.3390/gastroent16030035
|
| 2 |
Wei-Chen Tai, Lung-Sheng Lu, Shih-Cheng Yang, Hsin-Ming Wang, Cheng-Kun Wu, Chih-Chien Yao, Pao-Yuan Huang, Yu-Chi Lee, Seng-Kee Chuah, Chih-Ming Liang.
Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line
Helicobacter pylori
eradication: a randomized controlled trial
. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848251378066
|